Results 131 to 140 of about 17,628 (200)

Lurbinectedin in treating CNS metastases from small cell neuroendocrine prostate cancer-a case report. [PDF]

Front Oncol
Gunuganti A, Barve V, Kelly WJ, Gunuganti V, Brenner A.   +4 more
europepmc   +1 more source

Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High-Risk Neuroblastoma: A Multi-Institutional Retrospective Study. [PDF]

Pediatr Blood Cancer
Lerman BJ, King M, Mody R, Onyeama SJ, Marachelian A, Cash T, Federico SM, Granger M, Desai AV, Shusterman S, Foster JH, Sokol E, Greer C, Streby K, Meany HJ, Vo KT, Macy ME, Bagatell R.   +17 more
europepmc   +1 more source

Stability study of topotecan in ophthalmic prefilled syringes for intravitreal delivery. [PDF]

Eur J Hosp Pharm
Bello W, Hosotte C, Stampfli C, Pierrot A, Munier FL, Berger-Gryllaki M, Pezzatti J, Carrez L, Sadeghipour F.   +8 more
europepmc   +1 more source

HIGH-DOSE INTRAVITREAL TOPOTECAN (100 µ G/0.1 CC) AS MONOTHERAPY FOR RECURRENT/REFRACTORY INTRAOCULAR RETINOBLASTOMA IN SEVEN EYES. [PDF]

Retina
Vempuluru VS, Raval V, Kaliki S.
europepmc   +1 more source

FDA Approval Summary: Tarlatamab for the Treatment of Extensive-Stage Small Cell Lung Cancer. [PDF]

Clin Cancer Res
Liu Y, Nashed J, Barone AK, Yuan M, Amatya AK, Xiang Y, Zhao H, Bi Y, Pegues MA, Miller CP, Lane AR, Mixter BD, Tang S, Pazdur R, de Claro RA, Larkins E.   +15 more
europepmc   +1 more source

Comment on: Primary suspect drugs of cataracts in pediatric patients: FDA adverse events reporting database analysis. [PDF]

J Cataract Refract Surg
Rani T, Mandal R, Bandyopadhyay A.
europepmc   +1 more source

Reply : Primary suspect drugs of cataracts in pediatric patients: FDA adverse events reporting database analysis. [PDF]

J Cataract Refract Surg
Khan SM, Abboud I, Elhusseiny AM, Elhusseiny AM.   +3 more
europepmc   +1 more source

Place in therapy of key treatments for platinum-sensitive, relapsed, extensive-stage small cell lung cancer with a focus on lurbinectedin: a narrative review with case studies. [PDF]

Drugs Context
Shunyakov L, Badin FB, Hafer J, König D, Froesch P, Greillier L.   +5 more
europepmc   +1 more source

Treatment Sequencing in Platinum-Resistant Epithelial Ovarian Cancer After MIRASOL, KEYNOTE-B96, and ROSELLA. [PDF]

Int J Womens Health
Liu Y, Xu M, Ma J, Zhu Y, Gao M.
europepmc   +1 more source

High-Risk neuroblastoma therapeutics Topotecan and 13-cis-Retinoic acid modulate autophagy and induce DNA damage response in hematopoietic stem cells and monocytes. [PDF]

Sci Rep
Lázničková P, Tidu F, Hrdý J, Boráková K, Hortová Kohoutková M, Frič J.   +5 more
europepmc   +1 more source